These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Therapeutic response to progabide in neuroleptic- and L-dopa-induced dyskinesias. Ziegler M; Fournier V; Bathien N; Morselli PL; Rondot P Clin Neuropharmacol; 1987 Jun; 10(3):238-46. PubMed ID: 2900682 [TBL] [Abstract][Full Text] [Related]
45. Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Richardson MA; Haugland G; Craig TJ Am J Psychiatry; 1991 Oct; 148(10):1322-8. PubMed ID: 1680296 [TBL] [Abstract][Full Text] [Related]
46. Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Grant SM; Heel RC Drugs; 1991 Jun; 41(6):889-926. PubMed ID: 1715266 [TBL] [Abstract][Full Text] [Related]
47. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy. Bitton V; Melamed E J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157 [TBL] [Abstract][Full Text] [Related]
48. Naltrexone treatment of tardive dyskinesia in patients with schizophrenia. Wonodi I; Adami H; Sherr J; Avila M; Hong LE; Thaker GK J Clin Psychopharmacol; 2004 Aug; 24(4):441-5. PubMed ID: 15232337 [TBL] [Abstract][Full Text] [Related]
49. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group. Psychopharmacology (Berl); 1986; 90(4):423-9. PubMed ID: 2880362 [TBL] [Abstract][Full Text] [Related]
50. Clinical and biochemical effects of calcium-hopantenate on neuroleptics-induced tardive dyskinesia. Kashihara K; Ebara T; Yamamoto M; Ogawa T; Harada T; Otsuki S Folia Psychiatr Neurol Jpn; 1985; 39(2):147-53. PubMed ID: 2866149 [TBL] [Abstract][Full Text] [Related]
51. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia. Shoulson I Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445 [No Abstract] [Full Text] [Related]
52. Tardive dyskinesia and positive symptoms of schizophrenia. White T; Brown KW; Woods JP Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232 [TBL] [Abstract][Full Text] [Related]
53. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Richardson MA; Bevans ML; Read LL; Chao HM; Clelland JD; Suckow RF; Maher TJ; Citrome L Am J Psychiatry; 2003 Jun; 160(6):1117-24. PubMed ID: 12777270 [TBL] [Abstract][Full Text] [Related]